The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1018
January 16, 1998
View Complete Issue         Table of Contents 2019 
Budesonide Turbuhaler for Asthma
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Budesonide Turbuhaler for Asthma
January 16, 1998 (Issue: 1018)
The FDA has approved marketing of the corticosteroid budesonide in an oral inhalatoin powder formulation (Pulmicort Turbuhaler - Astra) for maintenance treatment of asthma in adults and children at least six years old. Budesonide has been available...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Budesonide Turbuhaler for Asthma
Article code: 1018b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.